Literature DB >> 9306007

Differences in the binding sites of two site-3 sodium channel toxins.

G R Benzinger1, C L Drum, L Q Chen, R G Kallen, D A Hanck, D Hanck.   

Abstract

Site-3 toxins from scorpion and sea anemone bind to Na channels and selectively inhibit current decay. Anthopleurins A and B (ApA and ApB, respectively), toxins found in the venom of the sea anemone Anthopleura xanthogrammica, bind to closed states of mammalian skeletal and cardiac Na channels with differing affinities which arise from differences in first-order toxin/channel dissociation rate constants, koff. Using chimera comprising domain interchanges between channel isoforms, we examined the structural basis of this differential affinity. Toxin/channel association rates, kon, were similar for both toxins and both parental channels. Domain 4 determined koff for ApA, while ApB dissociated from all tested chimera in a cardiac-like manner. To probe this surprising difference between two such closely related toxins, we examined the interaction of chimeric channels with a form of ApB in which the two nonconserved basic residues, Arg-12 and Lys-49, were converted to the corresponding neutral amino acids from ApA. In the chimera comprising domain 1 from the cardiac muscle isoform and domains 2-4 from the skeletal muscle isoform, toxin dissociated at a rate intermediate between those of the parental channels. We conclude that the differential component of ApA binding is controlled by domain 4 and that some component of ApB binding is not shared by ApA. This additional component probably binds to an interface between channel domains and is partly mediated by toxin residues Arg-12 and Lys-49.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9306007     DOI: 10.1007/s004240050460

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  14 in total

1.  Characterization of two Bunodosoma granulifera toxins active on cardiac sodium channels.

Authors:  C Goudet; T Ferrer; L Galàn; A Artiles; C F Batista; L D Possani; J Alvarez; A Aneiros; J Tytgat
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

Review 2.  Voltage-gated sodium channel modulation by scorpion alpha-toxins.

Authors:  Frank Bosmans; Jan Tytgat
Journal:  Toxicon       Date:  2006-09-28       Impact factor: 3.033

Review 3.  Site-3 toxins and cardiac sodium channels.

Authors:  Dorothy A Hanck; Michael F Sheets
Journal:  Toxicon       Date:  2006-09-27       Impact factor: 3.033

Review 4.  Sea anemone venom as a source of insecticidal peptides acting on voltage-gated Na+ channels.

Authors:  Frank Bosmans; Jan Tytgat
Journal:  Toxicon       Date:  2006-12-05       Impact factor: 3.033

Review 5.  Sea anemone toxins affecting voltage-gated sodium channels--molecular and evolutionary features.

Authors:  Yehu Moran; Dalia Gordon; Michael Gurevitz
Journal:  Toxicon       Date:  2009-03-05       Impact factor: 3.033

6.  The effect of recombinant neurotoxins from the sea anemone Anthopleura sp. on sodium currents of rat cerebral cortical neurons.

Authors:  Hui Xiang; Wucheng Tao; Lei Wang; Fang Wang; Anlong Xu
Journal:  Cell Mol Neurobiol       Date:  2008-06-26       Impact factor: 5.046

7.  Modulation of neuronal sodium channels by the sea anemone peptide BDS-I.

Authors:  Pin Liu; Sooyeon Jo; Bruce P Bean
Journal:  J Neurophysiol       Date:  2012-03-21       Impact factor: 2.714

8.  The role of the putative inactivation lid in sodium channel gating current immobilization.

Authors:  M F Sheets; J W Kyle; D A Hanck
Journal:  J Gen Physiol       Date:  2000-05       Impact factor: 4.086

Review 9.  Scorpion venom and the inflammatory response.

Authors:  Vera L Petricevich
Journal:  Mediators Inflamm       Date:  2010-03-14       Impact factor: 4.711

10.  State-dependent cocaine block of sodium channel isoforms, chimeras, and channels coexpressed with the beta1 subunit.

Authors:  S N Wright; S Y Wang; Y F Xiao; G K Wang
Journal:  Biophys J       Date:  1999-01       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.